PXD101 potentiates hormonal therapy and prevents the onset of castration-resistant phenotype modulating androgen receptor, HSP90, and CRM1 in preclinical models of prostate cancer.
暂无分享,去创建一个
A. Lenzi | E. Jannini | M. Motta | E. Di Cesare | V. Tombolini | M. Piccolella | G. Gravina | C. Festuccia | P. Muzi | P. Negri-Cesi | F. Marampon | A. Mancini | P. Negri‐Cesi